Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Duchesne

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Radical treatment for primary bladder cancer: where are we and where do we go from here? A reviewG M Duchesne
The Lancet. Oncology|March 22, 2002
Radiation for prostate cancerG M Duchesne
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Assessment of visual function for patients on tamoxifenG M Duchesne
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Fundamental bases of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapyG M Duchesne
European Journal of Nuclear Medicine|November 1, 1995
Oncology and nuclear medicine: a developing collaborationG M Duchesne
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
How should we palliate bladder cancer?A Lydon, G M Duchesne
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Androgens and prostate cancer: biology, pathology and hormonal therapyS M Galbraith, G M Duchesne
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Hemibody irradiation in lymphomas and related malignanciesG M Duchesne, C L Harmer
British Journal of Urology|June 1, 1994
Regression of lung metastases after local treatment of bone metastasis of renal adenocarcinomaG M Sadler, G M Duchesne
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Suramin and prostate cancer: the role of hydrocortisoneS J Harland, G M Duchesne
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Radical treatment for primary bladder cancer: where are we and where do we go from here? A reviewG M Duchesne
The Lancet. Oncology|March 22, 2002
Radiation for prostate cancerG M Duchesne
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Assessment of visual function for patients on tamoxifenG M Duchesne
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Fundamental bases of combined therapy in lung cancer: cell resistance to chemotherapy and radiotherapyG M Duchesne
European Journal of Nuclear Medicine|November 1, 1995
Oncology and nuclear medicine: a developing collaborationG M Duchesne
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1992
How should we palliate bladder cancer?A Lydon, G M Duchesne
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Androgens and prostate cancer: biology, pathology and hormonal therapyS M Galbraith, G M Duchesne
International Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Hemibody irradiation in lymphomas and related malignanciesG M Duchesne, C L Harmer
British Journal of Urology|June 1, 1994
Regression of lung metastases after local treatment of bone metastasis of renal adenocarcinomaG M Sadler, G M Duchesne
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Suramin and prostate cancer: the role of hydrocortisoneS J Harland, G M Duchesne
Pageof 3